investorscraft@gmail.com

Intrinsic Value of FMC Corporation (FMC)

Previous Close$38.01
Intrinsic Value
Upside potential
Previous Close
$38.01

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

FMC Corporation operates as a global agricultural sciences company, specializing in crop protection solutions through innovative insecticides, herbicides, and fungicides. The company serves large-scale agricultural producers and smaller farming operations, leveraging its R&D capabilities to develop sustainable and high-efficacy products. FMC’s revenue model is driven by chemical sales, licensing agreements, and tailored solutions for pest and disease management, positioning it as a key player in the agrochemical sector. The company competes with multinational firms like Bayer and Syngenta, differentiating itself through proprietary chemistries and a focus on emerging markets. Its market position is reinforced by a robust product pipeline and strategic partnerships with distributors and farmers worldwide. FMC’s ability to address evolving regulatory and environmental challenges further strengthens its industry standing.

Revenue Profitability And Efficiency

FMC reported revenue of $4.25 billion for FY 2024, with net income of $339.9 million, reflecting a net margin of approximately 8%. Diluted EPS stood at $2.72, while operating cash flow reached $671.1 million, indicating solid cash generation. The absence of reported capital expenditures suggests disciplined spending or potential data limitations, warranting further scrutiny.

Earnings Power And Capital Efficiency

The company’s earnings power is supported by its agrochemical portfolio, though net income margins indicate moderate profitability. Operating cash flow coverage of net income (1.97x) suggests efficient cash conversion. However, high total debt of $3.5 billion relative to cash reserves ($357.3 million) raises questions about leverage management and capital allocation efficiency.

Balance Sheet And Financial Health

FMC’s balance sheet shows $357.3 million in cash against $3.5 billion in total debt, highlighting a leveraged position. The debt-to-equity ratio appears elevated, potentially constraining financial flexibility. Shareholders’ equity and liquidity metrics would provide deeper insight, but absent data limits a full assessment of solvency risks.

Growth Trends And Dividend Policy

FMC’s dividend payout of $2.33 per share suggests a commitment to returning capital, though the sustainability depends on future cash flows and debt servicing. Growth prospects hinge on product innovation and expansion in emerging markets, but macroeconomic and regulatory headwinds in agriculture could temper near-term performance.

Valuation And Market Expectations

With a market cap inferred from shares outstanding (124.9 million) and assuming a typical trading range, FMC’s valuation likely reflects moderate growth expectations. Investors may weigh its agrochemical niche against sector volatility and input cost pressures, pricing in a risk premium for its leveraged balance sheet.

Strategic Advantages And Outlook

FMC’s strengths lie in its R&D-driven product portfolio and global distribution network. However, debt levels and competitive pressures pose challenges. The outlook depends on executing innovation cycles and managing leverage, with sustainability initiatives potentially unlocking long-term value in a shifting regulatory landscape.

Sources

FMC Corporation 10-K (CIK: 0000037785), FY 2024 preliminary data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount